|
|
||||||||
Endocrinology and Metabolism |
1 INSERM ERM 0322 Hôpital Debrousse, Lyon, France.
2 Université de Lyon, Université Lyon 1, ISPB, Lyon, France,
3 Service de Radioanalyse, Centre de Médecine Nucléaire, and6
Fédération dEndocrinologie and Hôpital Neurologique et Cardiologique (Hospices Civils de Lyon), Bron, France.
4 International Agency for Research on Cancer, Lyon, France.
5 Département de Médecine de la Reproduction, Hôpital Edouard, Herriot, and InSERM-INRA U418, Hôpital Debrousse, Lyon, France.
aAddress correspondence to this author at: Service de Radioanalyse, Centre de Médecine Nucléaire, Hôpital Neurologique et Cardiologique, 59 boul. Pinel, Bron 69394, France. E-mail henri.dechaud{at}chu-lyon.fr.
Background: Bioavailable testosterone (BT) concentration is considered the best marker for evaluating testicular function in men. The decrease of BT in older men is more pronounced than the decrease in total testosterone because of the parallel increase in sex hormonebinding globulin (SHBG) concentrations. Measurement of BT is therefore crucial for the diagnosis of hypoandrogenism in the aging male population.
Methods: We compared BT concentrations measured by a specific RIA after ammonium sulfate precipitation (BTmeas) with those obtained by theoretical calculations (BTcal) in plasma samples from 694 young men (14 to 49 years old) and 51 older men (50 to 81 years old). We based theoretical calculations on Vermeulens simplified mass equation using total testosterone and SHBG concentrations.
Results: BTcal and BTmeas correlated significantly in young (Pearson r = 0.87) and aging (r = 0.89) men, but the BTcal:BTmeas ratio differed markedly between the 2 groups (2.28 vs 3.48; P <0.001).
Conclusions: In men, there is an age-associated discrepancy between calculated and measured BT concentrations. We suggest some hypotheses for the discrepancy, but additional studies will be performed to finally elucidate this difference in results and to determine the most appropriate method for BT measurements in older men.
The following articles in journals at HighWire Press have cited this article:
![]() |
F. Giton, S. Urien, C. Born, J. Tichet, J. Guechot, J. Callebert, F. Bronsard, J. P. Raynaud, and J. Fiet Determination of Bioavailable Testosterone [Non Sex Hormone Binding Globulin (SHBG)-Bound Testosterone] in a Population of Healthy French Men: Influence of Androstenediol on Testosterone Binding to SHBG Clin. Chem., December 1, 2007; 53(12): 2160 - 2168. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |